Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 26 May 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Allogeneic CAR T-Cells
    Autologous CAR T-Cells

Market segment by Application, can be divided into
    Hospital
    Diagnostic Center
    Others

Market segment by players, this report covers
    Pfizer
    Novartis
    Bristol Myers Squibb
    Legend Biotech
    Sorrento Therapeutics
    CARSGEN Therapeutics，Ltd
    Juno Therapeutics
    Kite Pharma
    Atara Biotherapeutics
    Carina Biotech
    Guangzhou Xiangxue Pharmaceutical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, with revenue, gross margin and global market share of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy from 2019 to 2021.
Chapter 3, the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    1.2 Classification of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Type
        1.2.1 Overview: Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type in 2020
        1.2.3 Allogeneic CAR T-Cells
        1.2.4 Autologous CAR T-Cells
    1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market by Application
        1.3.1 Overview: Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital
        1.3.3 Diagnostic Center
        1.3.4 Others
    1.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size & Forecast
    1.5 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast by Region
        1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region, (2016-2021)
        1.5.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.6 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
        1.6.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints
        1.6.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Trends Analysis

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.1.4 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.2.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Bristol Myers Squibb
        2.3.1 Bristol Myers Squibb Details
        2.3.2 Bristol Myers Squibb Major Business
        2.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.3.4 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.4 Legend Biotech
        2.4.1 Legend Biotech Details
        2.4.2 Legend Biotech Major Business
        2.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.4.4 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Legend Biotech Recent Developments and Future Plans
    2.5 Sorrento Therapeutics
        2.5.1 Sorrento Therapeutics Details
        2.5.2 Sorrento Therapeutics Major Business
        2.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.5.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.6 CARSGEN Therapeutics，Ltd
        2.6.1 CARSGEN Therapeutics，Ltd Details
        2.6.2 CARSGEN Therapeutics，Ltd Major Business
        2.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.6.4 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 CARSGEN Therapeutics，Ltd Recent Developments and Future Plans
    2.7 Juno Therapeutics
        2.7.1 Juno Therapeutics Details
        2.7.2 Juno Therapeutics Major Business
        2.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.7.4 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Juno Therapeutics Recent Developments and Future Plans
    2.8 Kite Pharma
        2.8.1 Kite Pharma Details
        2.8.2 Kite Pharma Major Business
        2.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.8.4 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Kite Pharma Recent Developments and Future Plans
    2.9 Atara Biotherapeutics
        2.9.1 Atara Biotherapeutics Details
        2.9.2 Atara Biotherapeutics Major Business
        2.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.9.4 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Atara Biotherapeutics Recent Developments and Future Plans
    2.10 Carina Biotech
        2.10.1 Carina Biotech Details
        2.10.2 Carina Biotech Major Business
        2.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.10.4 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Carina Biotech Recent Developments and Future Plans
    2.11 Guangzhou Xiangxue Pharmaceutical
        2.11.1 Guangzhou Xiangxue Pharmaceutical Details
        2.11.2 Guangzhou Xiangxue Pharmaceutical Major Business
        2.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
        2.11.4 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Guangzhou Xiangxue Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Market Share
        3.2.2 Top 10 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
    5.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)
    6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)
    6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        6.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)
        6.3.2 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)
    7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)
    7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        7.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)
        7.3.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.3 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
        8.3.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2016-2026)
        8.3.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)
    9.2 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)
    9.3 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        9.3.1 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)
        9.3.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        10.3.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2026)
        10.3.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2021-2026)
    Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 7. Pfizer Major Business
    Table 8. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 9. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Novartis Corporate Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 13. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
    Table 15. Bristol Myers Squibb Major Business
    Table 16. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 17. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Legend Biotech Corporate Information, Head Office, and Major Competitors
    Table 19. Legend Biotech Major Business
    Table 20. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 21. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 23. Sorrento Therapeutics Major Business
    Table 24. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 25. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. CARSGEN Therapeutics，Ltd Corporate Information, Head Office, and Major Competitors
    Table 27. CARSGEN Therapeutics，Ltd Major Business
    Table 28. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 29. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Juno Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 31. Juno Therapeutics Major Business
    Table 32. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 33. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Kite Pharma Corporate Information, Head Office, and Major Competitors
    Table 35. Kite Pharma Major Business
    Table 36. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 37. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Atara Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Atara Biotherapeutics Major Business
    Table 40. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 41. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Carina Biotech Corporate Information, Head Office, and Major Competitors
    Table 43. Carina Biotech Major Business
    Table 44. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 45. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Guangzhou Xiangxue Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 47. Guangzhou Xiangxue Pharmaceutical Major Business
    Table 48. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Solutions
    Table 49. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Players (2019-2021)
    Table 51. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Players (2019-2021)
    Table 52. Breakdown of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Head Office, Products and Services Provided
    Table 54. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Mergers & Acquisitions in the Past Five Years
    Table 55. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy New Entrants and Expansion Plans
    Table 56. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) by Type (2016-2021)
    Table 57. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Type (2016-2021)
    Table 58. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Forecast by Type (2021-2026)
    Table 59. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021)
    Table 60. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Forecast by Application (2021-2026)
    Table 61. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)
    Table 62. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)
    Table 63. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)
    Table 64. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)
    Table 65. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)
    Table 66. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)
    Table 67. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)
    Table 68. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)
    Table 69. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)
    Table 70. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)
    Table 71. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)
    Table 72. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)
    Table 73. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)
    Table 74. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)
    Table 75. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)
    Table 76. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)
    Table 77. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2016-2021) & (USD Million)
    Table 78. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Region (2021-2026) & (USD Million)
    Table 79. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)
    Table 80. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)
    Table 81. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)
    Table 82. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)
    Table 83. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)
    Table 84. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)
    Table 85. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million)
    Table 86. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million)
    Table 87. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million)
    Table 88. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million)
    Table 89. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million)
    Table 90. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Picture
    Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type in 2020
    Figure 3. Allogeneic CAR T-Cells
    Figure 4. Autologous CAR T-Cells
    Figure 5. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application in 2020
    Figure 6. Hospital Picture
    Figure 7. Diagnostic Center Picture
    Figure 8. Others Picture
    Figure 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2016-2026)
    Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region in 2020
    Figure 13. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
    Figure 19. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints
    Figure 20. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
    Figure 21. Pfizer Recent Developments and Future Plans
    Figure 22. Novartis Recent Developments and Future Plans
    Figure 23. Bristol Myers Squibb Recent Developments and Future Plans
    Figure 24. Legend Biotech Recent Developments and Future Plans
    Figure 25. Sorrento Therapeutics Recent Developments and Future Plans
    Figure 26. CARSGEN Therapeutics，Ltd Recent Developments and Future Plans
    Figure 27. Juno Therapeutics Recent Developments and Future Plans
    Figure 28. Kite Pharma Recent Developments and Future Plans
    Figure 29. Atara Biotherapeutics Recent Developments and Future Plans
    Figure 30. Carina Biotech Recent Developments and Future Plans
    Figure 31. Guangzhou Xiangxue Pharmaceutical Recent Developments and Future Plans
    Figure 32. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Players in 2020
    Figure 33. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 34. Global Top 3 Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share in 2020
    Figure 35. Global Top 10 Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share in 2020
    Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 37. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Type in 2020
    Figure 38. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share Forecast by Type (2021-2026)
    Figure 39. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Application in 2020
    Figure 40. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share Forecast by Application (2021-2026)
    Figure 41. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)
    Figure 42. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)
    Figure 43. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)
    Figure 44. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)
    Figure 48. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)
    Figure 49. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)
    Figure 56. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2016-2026)
    Figure 58. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)
    Figure 65. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)
    Figure 66. South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2016-2026)
    Figure 70. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Application (2016-2026)
    Figure 71. Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical

Related Reports

Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 15 Jan 2022

date Medical Care

The Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

chimeric antigen receptor car t cell immunotherapy

Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>